Introduction
Updates about Psoriasis and Alopecia Areata management
Objectives
Communicate Baricitinib and Ixekizumab value proposition in a speaker program setting to communicate what the product may mean to people living with Alopecia Areata and Psoriasis Diseases
This Course For :
Physician
( Dermatology )
Resident / Fellow
( Dermatology )
Pharmacy
Speaker
Dr Abdulhadi Jfri
Assistant Professor of Dermatology
Consultant dermatologist, King Abdulaziz Medical City (NGH), Jeddah
Dr. Abdullah Alkhalifa, MD
Adjunct Assistant Professor, College of Medicine, Imam Mohammad Ibn Saud Islamic University, Riyadh, KSA
Consultant dermatologist, Prince Sultan Military Medical City, Riyadh, KSA
Dr. Afaf Abdulaziz Al-Sheikh, MD, FAAD
Consultant Dermatologist
Head division of Dermatology,
Department of Medicine
King Abdulaziz Medical City, Riyadh
Assistant Professor, King Saud Bin
Abdulaziz University for Health
Sciences
Provided by :
Price
Course Fee
FREE
FREE
Contact Information
Organization : Virtual Medical AcademyPhone : 920008161
Email : [email protected]
Free
22 Jul 2025 To 22 Jul 2025 -
09:00 PM To 10:30 PM 
Certificate Available 
Online Click Here
- 127
Add to Calendar
07/22/2025 09:00 PM
07/22/2025 10:30 PM
Asia/ Riyadh
Redefining Alopecia Areata Management with Baricitinib Transition from Clinical Trials to RWE in Plaque Psoriasis
Redefining Alopecia Areata Management with Baricitinib Transition from Clinical Trials to RWE in Plaque Psoriasis
https://medicalacademy.org/portal/event/view/2414
